TPMT gene polymorphisms: On the doorstep of personalized medicine

Indian Journal of Medical Research

Volumn 129, Issue 5, 2009, Pages 478-480

  Pavlovic, Sonja ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

MERCAPTOPURINE; THIOPURINE METHYLTRANSFERASE;

ACUTE LYMPHOBLASTIC LEUKEMIA; AUTOIMMUNE DISEASE; BLOOD TOXICITY; DNA POLYMORPHISM; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG INDUCED DISEASE; ENZYME ACTIVITY; ENZYME ASSAY; ETHNIC DIFFERENCE; GENETIC ANALYSIS; GENETIC MARKER; GENETIC VARIABILITY; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HUMAN; INFLAMMATORY DISEASE; NOTE; PHARMACOGENETICS; RELIABILITY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SHORT TANDEM REPEAT; SINGLE NUCLEOTIDE POLYMORPHISM; VARIABLE NUMBER OF TANDEM REPEAT;

GENETIC MARKERS; GENETICS, POPULATION; GENOTYPE; HUMANS; INDIVIDUALIZED MEDICINE; METHYLTRANSFERASES; PHARMACOGENETICS; POLYMORPHISM, GENETIC;

EID: 70349137184     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Note

References (18)

1. Kidd KK, Pakstis AJ, Speed WC, Kidd JR. Understanding human DNA sequence variation. J Hered 2004; 95: 406-20.
2. Weinshilboum RM, Raymond FA, Pazmino PA. Human erythrocyte thiopurine methyltransferase: radiochemical microassay and biochemical properties. Clin Chim Acta 1978; 85: 323-33.
3. Krynetski EY, Tai HL, Yates CR, Fessing MY, Loennechen T, Schuetz JD. Genetic polymorphism of thiopurine S-methyltransferase: clinical importance and molecular mechanisms. Pharmacogenetics 1996; 6: 279-90.
4. Balis FM, Holcenberg JS, Poplack DG. General principles of chemotherapy. In: Pizzo AP, Poplack DG, editors. Principles and practice of pediatric oncology. 4th ed. Philadelphia: JB Lippincott Company; 2001. p. 210-45.
5. Weinshilboum RM, Sladek SL. Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity. Am J Hum Genet 1980; 32: 651-62.
6. Dokmanovic L, Urosevic J, Janic D, Jovanovic N, Petrucev B, Tosic N, et al. Analysis of thiopurine S-methyltransferase polymorphism in the population of Serbia and Montenegro and mercaptopurine therapy tolerance in childhood acute lymphoblastic leukemia. Ther Drug Monit 2006; 28: 800-6.
7. Garat A, Cauffiez C, Renault N, Lo-Guidice JM, Allorge D, Chevalier D, et al. Characterisation of novel defective thiopurine S-methyltransferase allelic variants. Biochem Pharmacol 2008; 76: 404-15.
8. Szumlanski C, Otterness D, Her C, Lee D, Brandriff B, Kelsell D. Thiopurine methyltransferase pharmacogenetics: human gene cloning and characterization of a common polymorphism. DNA Cell Biol 1996; 15: 17-30.
9. De la Moureyre SC, Debuysere H, Mustain B. Genotypic and phenotypic analysis of the polymorphic thiopurine S-methyltransferase gene (TPMT) in European population. Br J Pharmacol 1998; 125: 879-87.
10. Hon YY, Fessing MY, Pui CH, Relling MV, Krynetski EY, Evans WE. Polymorphism of the thiopurine S-methyltransferase gene in African-Americans. Hum Mol Genet 1999; 8: 371-6.
11. Collie-Duguid ES, Pritchard SC, Powrie RH, Sludden J, Collier DA, Li T, et al. The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations. Pharmacogenetics 1999; 9: 37-42.
12. Schaffeler E, Fischer C, Brockmeier D, Wernet D, Moerike K, Eichelboum M, et al. Comprehensive analysis of thiopurine S-methyltransferase phenotype-genotype correlation in a large population of German-Caucasians and identification of novel TPMT variants. Pharmacogenetics 2004; 14: 407-17.
13. Kapoor G, Maitra A, Somlata, Brahmachari V. Application of SNaPshot for analysis of thiopurine methyltransferase gene polymorphism. Indian J Med Res 2009; 129: 500-5.
14. Yates CR, Krynetski EY, Loennechen T, Fessing MY, Tai HL, Pui CH, et al. Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance. Ann Intern Med 1997; 126: 608-14.
15. Schrappe M, Camitta B, Pui CH, Eden T, Gaynon P, Gustafsson G, et al. Long-term results of large prospective trials in childhood acute lymphoblastic leukemia. Leukemia 2000; 14: 2193-4.
16. Pui CH, Relling MV, Evans WE. Role of pharmacogenomics and pharmacodynamics in the treatment of acute lymphoblastic leukaemia. Best Pract Res Clin Haematol 2003; 15: 741-56.
17. Kham SKY, Soh CK, Liu TC, Chan YH, Ariffin H, Tan PL, et al. Thiopurine S-methyltransferase activity in three major Asian populations: a population-based study in Singapore. Eur J Clin Pharmacol 2008; 64: 373-9.
18. Weinshilboum R, Wang L. Thiopurine S-methyltransferase pharmacogenetics: insights, challenges and future directions. Oncogene 2006; 25: 1629-38.